Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets
Biotin-thiamine-responsive basal ganglia disease, first described in 1998 by Ozand et al., is an autosomal recessive disorder that is most commonly observed in the Saudi Arabian population
It is not approved for human consumption or medical application
Diseases of the nervous system due to nutritional deficiency
US$ 27.05
US$ 20.73
US$ 22.59
US$ 28.85
US$ 20.01
